As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations

The EMA has increased its forecast of the proportion of staff that will relocate with it to Amsterdam. Buoyed by the improved outlook, the agency has predicted its core drug evaluation activities will be unaffected by the Brexit-enforced move.